Entering text into the input field will update the search result below

U.S. FTC clears Novartis buy of Glaxo cancer drugs, with conditions

Feb. 23, 2015 12:42 PM ETNovartis AG (NVS) StockGSK, NVSBy: Douglas W. House, SA News Editor
  • The Federal Trade Commission in the U.S. approves Novartis' (NVS +0.1%) purchase of GlaxoSmithKline's (GSK -0.1%) oncology business for $16B, contingent on the divestment of the BRAF and MEK inhibitors.
  • Previously: Why Glaxo bids adieu to cancer drugs (April 22, 2014)

Recommended For You

More Trending News

About NVS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NVS--
Novartis AG